Elevance Health (ELV) EV to EBIT (2009 - 2026)

Elevance Health (ELV) has reported EV to EBIT for 18 consecutive years, with 68.25 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBIT fell 38.26% year-over-year to 68.25 in Q2 2026; TTM through Jun 2026 was 18.57, a 25.53% decrease from a year earlier, with the FY2025 full-year figure at 19.21, down 22.05% from the prior year.
• EV to EBIT was 68.25 for Q2 2026 at Elevance Health, up from 36.88 in the prior quarter.
• Over five years, EV to EBIT peaked at 239.25 in Q1 2022 and troughed at 36.88 in Q1 2026.
• A 5-year average of 143.92 and a median of 145.94 in 2023 frame the typical range for EV to EBIT.
• Across the five-year window, EV to EBIT jumped 41.46% in 2022 and slumped 66.69% in 2026, its largest moves.
• Over 5 years, EV to EBIT stood at 238.11 in 2022, then tumbled by 41.36% to 139.63 in 2023, then plunged by 31.32% to 95.9 in 2024, then declined by 10.86% to 85.48 in 2025, then fell by 20.16% to 68.25 in 2026.
• The last three EV to EBIT figures came in at 68.25 (Q2 2026), 36.88 (Q1 2026), and 85.48 (Q4 2025), per Business Quant data.